iPath MSCI India ETN
INP
New York Stock Exchange Arca- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 50 Hudson Yards New York NY United States of America 10001
- IPO Date
- Dec 20, 2006
- Website
- barclaysinvestments.co.uk
- Similar Companies
- Business
- iPath MSCI India ETN (INP) is an exchange-traded note issued by Barclays Bank PLC that provides exposure to the MSCI India Index, tracking the performance of large- and mid-cap Indian equity securities; the ETN delivers a cash payment based on the index's total return at maturity or early redemption, subject to the investor fee and Barclays' credit risk. Launched on December 19, 2006, and listed on NYSE Arca, it targets investors seeking India-specific equity market returns without direct ownership of underlying stocks. The ETN is part of Barclays' iPath series of senior, unsecured debt securities focused on commodities, equities, volatility, and other asset classes. The product offers synthetic exposure to approximately 79 holdings in the MSCI India Total Return Index, with significant concentration in top sectors such as financials, technology, and consumer goods; as of recent data, top 10 holdings represent around 46% of assets. It operates globally through U.S. exchanges, with Barclays headquartered in London, United Kingdom, and the ETN available to institutional and retail investors worldwide. No dividends are paid, and returns are linked to the index's volume-weighted average price rather than closing levels. In a major recent development, Barclays has pursued issuer call options and tender offers for numerous iPath ETNs, including amendments to indentures enabling full redemptions, though INP was not explicitly listed among those redeemed by June 2025; similar actions affected related series in 2024-2025, signaling a strategic wind-down of legacy iPath products. Previously, in 2020, Barclays announced a redemption plan for INP specifically, highlighting ongoing portfolio rationalization efforts. These changes reflect Barclays' shifts toward newer structured products amid market and regulatory evolutions.